Health and Human Services Secretary Robert F. Kennedy Jr., confirmed by the Senate in February 2025 on a 52-48 vote, continues to lead the department amid ongoing agency overhauls, driving trader consensus toward a 70.5% implied probability that he will not depart by December 31, 2026. Recent developments, including his April 2026 congressional testimonies defending the Trump administration's budget requests and healthcare priorities against Democratic scrutiny, underscore his entrenched position. Subordinate exits, such as the chief HHS spokesperson's resignation on May 13 over e-cigarette policy and the FDA commissioner's departure under pressure, reflect internal turbulence but no signals of Kennedy's own resignation or dismissal. His midterm travel push to bolster "Make America Healthy Again" initiatives further signals staying power through the election cycle.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$18,824 Vol.
$18,824 Vol.
$18,824 Vol.
$18,824 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Health and Human Services Secretary Robert F. Kennedy Jr., confirmed by the Senate in February 2025 on a 52-48 vote, continues to lead the department amid ongoing agency overhauls, driving trader consensus toward a 70.5% implied probability that he will not depart by December 31, 2026. Recent developments, including his April 2026 congressional testimonies defending the Trump administration's budget requests and healthcare priorities against Democratic scrutiny, underscore his entrenched position. Subordinate exits, such as the chief HHS spokesperson's resignation on May 13 over e-cigarette policy and the FDA commissioner's departure under pressure, reflect internal turbulence but no signals of Kennedy's own resignation or dismissal. His midterm travel push to bolster "Make America Healthy Again" initiatives further signals staying power through the election cycle.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions